Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

26,369 public trials 3,582 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

The INFLUENCE of Cytoreduction on PRO in EOC

NCT03268876

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Sørlandet sykehus HF Kristiansand, Norway
  • Stavanger University Hospital Stavanger, Norway
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

NCT02521844

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • University of Arizona Cancer Center, 3838 N. Campbell Avenue, RM 2111, Site 203 Tucson, Arizona, United States
  • Chao Family Comprehensive Cancer Center,Stern Center for Cancer Clinical Trials and Research, 101 City Drive South, Site 209 Orange, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavilion, 12648 East 17th Avenue; MSF 700, Site 202 Aurora, Colorado, United States
  • University of Kansas Medical Center, 4350 Shawnee Mission Parkway, Suite 2310, MS 6004, Site 210 Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

NCT05399446

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +12 more
Locations
  • Stanford University Stanford, California, United States
  • Joslin Diabetes Center Boston, Massachusetts, United States
  • Amsterdam Medical University Center Amsterdam, Netherlands
  • Oslo University Hospital Oslo, Norway
View Trial Details

Related conditions